Literature DB >> 9183635

[Proliferation and differentiation of human salivary gland adenocarcinoma cell line HSG].

M Ota1, S Kyakumoto, N Sato.   

Abstract

The adenocarcinoma cell line derived from an intercalated ductal epithelium of a human salivary gland (HSG) proliferates autonomously mediated by an epidermal growth factor-(EGF)-like molecule with a molecular weight of 46 kDa and an EGF receptor (EGFR). The c-erbB2 protein, a member of EGFR family was also expressed in HSG cells and was involved in the growth signal pathway of HSG cells as well as EGFR. The autocrine growth is regulated by glucocorticoid and retinoic acid (RA) via their receptors. Retinoic acid receptor (RAR) of HSG cells revealed a transcriptional activity in vivo, and the heterodimerization between RAR and 9-cis retinoic acid receptor (RXR) is requisite for the binding with a specific DNA element termed RA response element in vitro. RXR alpha and RXR beta were cloned from HSG cells, and these RXRs, together with RAR, seemed to play a physiological role in RA signaling in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9183635

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  2 in total

1.  Exogenous expression of caspase-14 induces tumor suppression in human salivary cancer cells by inhibiting tumor vascularization.

Authors:  Mengjie Wu; Isamu Kodani; Douglas Dickinson; Frank Huff; Kalu U E Ogbureke; Haiyan Qin; Senthil Arun; Rachel Dulebohn; Mohamed Al-Shabrawey; Amany Tawfik; Susan Prater; Jill Lewis; John Wataha; Regina Messer; Stephen Hsu
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

2.  Epigallocatechin-3-gallate prevents autoimmune-associated down- regulation of p21 in salivary gland cells through a p53-independent pathway.

Authors:  Douglas Dickinson; Hongfang Yu; Seiji Ohno; Cristina Thomas; Scott Derossi; Yat-Ho Ma; Nicole Yates; Emily Hahn; Frederick Bisch; Tetsuya Yamamoto; Stephen Hsu
Journal:  Inflamm Allergy Drug Targets       Date:  2014-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.